NO961429L - Fremgangsmåte for fremstilling av kinolonholdige, orale preparater - Google Patents
Fremgangsmåte for fremstilling av kinolonholdige, orale preparaterInfo
- Publication number
- NO961429L NO961429L NO961429A NO961429A NO961429L NO 961429 L NO961429 L NO 961429L NO 961429 A NO961429 A NO 961429A NO 961429 A NO961429 A NO 961429A NO 961429 L NO961429 L NO 961429L
- Authority
- NO
- Norway
- Prior art keywords
- quinolone
- preparation
- oral preparations
- containing oral
- introducing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9312550A FR2711524B1 (fr) | 1993-10-21 | 1993-10-21 | Procédé de préparation de compositions orales contenant des quinolones. |
| PCT/FR1994/001212 WO1995011023A1 (fr) | 1993-10-21 | 1994-10-19 | Procede de preparation de compositions orales contenant des quinolones |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO961429D0 NO961429D0 (no) | 1996-04-11 |
| NO961429L true NO961429L (no) | 1996-04-11 |
Family
ID=9452072
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO961429A NO961429L (no) | 1993-10-21 | 1996-04-11 | Fremgangsmåte for fremstilling av kinolonholdige, orale preparater |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US5840333A (es) |
| EP (1) | EP0724442A1 (es) |
| AT (1) | ATA905894A (es) |
| AU (1) | AU7997094A (es) |
| BE (1) | BE1007326A3 (es) |
| CA (1) | CA2174444A1 (es) |
| CH (1) | CH686555A5 (es) |
| CO (1) | CO4180603A1 (es) |
| CZ (1) | CZ113696A3 (es) |
| DZ (1) | DZ1818A1 (es) |
| EE (1) | EE9600050A (es) |
| ES (1) | ES2126474B1 (es) |
| FI (1) | FI961717A0 (es) |
| FR (1) | FR2711524B1 (es) |
| GB (1) | GB2297908B (es) |
| GR (1) | GR1002181B (es) |
| HU (1) | HUT74181A (es) |
| IE (1) | IE940838A1 (es) |
| IT (1) | IT1270672B (es) |
| MA (1) | MA23331A1 (es) |
| NO (1) | NO961429L (es) |
| NZ (1) | NZ274874A (es) |
| OA (1) | OA10282A (es) |
| PL (1) | PL314005A1 (es) |
| SG (1) | SG52202A1 (es) |
| SK (1) | SK50596A3 (es) |
| TN (1) | TNSN94110A1 (es) |
| WO (2) | WO1995011022A1 (es) |
| ZA (1) | ZA948175B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2277682T3 (es) * | 1998-06-11 | 2007-07-16 | PHARMACIA & UPJOHN COMPANY LLC | Formulacion de delavirdina en comprimido. |
| US6342598B1 (en) | 1998-11-26 | 2002-01-29 | Bracco International B.V. | Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as MRI contrast agents |
| UA89793C2 (uk) | 2004-08-13 | 2010-03-10 | Шерінг-Плау Лтд. | Фармацевтична композиція, яка містить антибіотик, триазол і кортикостероїд |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4639458A (en) * | 1985-01-22 | 1987-01-27 | Merck & Co., Inc. | Tablet and formulation |
| JPH01175936A (ja) * | 1987-12-28 | 1989-07-12 | Kyorin Pharmaceut Co Ltd | ６．８−ジフルオロ−１−（２−フルオロエチル）−１，４−ジヒドロ−７−（４−メチル−１−ピペラジニル）−４−オキソ−３−キノリンカルボン酸を有効成分とする錠剤 |
| US4973470A (en) * | 1989-06-26 | 1990-11-27 | Warner-Lambert Company | Sustained release pharmaceutical compositions |
| JPH10175936A (ja) * | 1996-12-17 | 1998-06-30 | Kao Corp | 新規アミドアミノポリカルボン酸又はその塩、及びそれを含有する洗浄剤組成物 |
-
1993
- 1993-10-21 FR FR9312550A patent/FR2711524B1/fr not_active Expired - Fee Related
-
1994
- 1994-09-15 MA MA23651A patent/MA23331A1/fr unknown
- 1994-10-18 ZA ZA948175A patent/ZA948175B/xx unknown
- 1994-10-19 GB GB9608316A patent/GB2297908B/en not_active Expired - Fee Related
- 1994-10-19 CZ CZ961136A patent/CZ113696A3/cs unknown
- 1994-10-19 SK SK505-96A patent/SK50596A3/sk unknown
- 1994-10-19 EP EP94931613A patent/EP0724442A1/fr not_active Withdrawn
- 1994-10-19 WO PCT/FR1994/001211 patent/WO1995011022A1/fr not_active Application Discontinuation
- 1994-10-19 EE EE9600050A patent/EE9600050A/xx unknown
- 1994-10-19 IT ITMI942130A patent/IT1270672B/it active IP Right Grant
- 1994-10-19 US US08/632,394 patent/US5840333A/en not_active Expired - Fee Related
- 1994-10-19 ES ES009550022A patent/ES2126474B1/es not_active Expired - Lifetime
- 1994-10-19 BE BE9400944A patent/BE1007326A3/fr not_active IP Right Cessation
- 1994-10-19 SG SG1996000170A patent/SG52202A1/en unknown
- 1994-10-19 HU HU9601041A patent/HUT74181A/hu unknown
- 1994-10-19 CA CA002174444A patent/CA2174444A1/fr not_active Abandoned
- 1994-10-19 DZ DZ940108A patent/DZ1818A1/fr active
- 1994-10-19 GR GR940100472A patent/GR1002181B/el unknown
- 1994-10-19 NZ NZ274874A patent/NZ274874A/en unknown
- 1994-10-19 WO PCT/FR1994/001212 patent/WO1995011023A1/fr not_active Application Discontinuation
- 1994-10-19 CH CH01837/95A patent/CH686555A5/fr not_active IP Right Cessation
- 1994-10-19 AU AU79970/94A patent/AU7997094A/en not_active Abandoned
- 1994-10-19 PL PL94314005A patent/PL314005A1/xx unknown
- 1994-10-19 AT AT0905894A patent/ATA905894A/de unknown
- 1994-10-20 IE IE940838A patent/IE940838A1/en not_active IP Right Cessation
- 1994-10-20 CO CO94047881A patent/CO4180603A1/es unknown
- 1994-10-21 TN TNTNSN94110A patent/TNSN94110A1/fr unknown
-
1996
- 1996-04-11 NO NO961429A patent/NO961429L/no unknown
- 1996-04-19 FI FI961717A patent/FI961717A0/fi unknown
- 1996-04-19 OA OA60816A patent/OA10282A/fr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE04800B1 (et) | Oraalne manustamisvorm happes ebapüsiva toimeainetarbeks, toimeaineühik, selle valmistamismeetod ja kasutamine ning meetod oraalse manustamisvormi valmistamiseks | |
| TR199802698T2 (xx) | Valsartan�n kat� oral doz formlar�. | |
| NO843563L (no) | Fremgangsmaate ved fremstilling av farmasoeytiske preparater med hoeyt innhold av aktiv bestanddel som frigjoeres over lengre tid | |
| HUP0004383A2 (hu) | Hatóanyagként klodronátot és vivőanyagként szilíciumozott mikrokristályos cellulózt tartalmazó gyógyszerészeti készítmény | |
| EE9700328A (et) | Tahke oraalne preparaat, mis sisaldab toimeainena olansapiini, selle valmistamismeetod ja kasutamine | |
| EP0348808A3 (de) | Neue Arzneimittelformulierung sowie Verfahren zu deren Herstellung | |
| NO20002605L (no) | Sferoider, fremstillingsmetode og farmasøytiske sammensetninger | |
| BG103000A (en) | Compositions for single daily dosage in the treatment of cyclooxygenase-2-dependent diseases | |
| NO982414L (no) | Ny kombinasjon | |
| TW221056B (es) | ||
| NZ318282A (en) | Pharmaceutical formulation containing amoxycillin and clavulanate in a weight ratio of 12:1 and 20:1 | |
| SE8505736L (sv) | Beredningar, huvudsakligen konfektberedningar, som reducerar tandkariesfrekvensen samt forfarande for framstellning av dessa beredningar | |
| FR2771292B1 (fr) | Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiques | |
| HUP0105481A2 (hu) | Klaritromicint vagy származékait tartalmazó gyógyászati készítmények és eljárás előállításukra, valamint alkalmazásuk | |
| SI1274685T1 (sl) | Derivat piridin-1-oksida in postopek njegove transformacije v farmacevtsko ucinkovite sestavine | |
| AU583166B2 (en) | Oral garlic preparations and process for preparing same | |
| NO961429L (no) | Fremgangsmåte for fremstilling av kinolonholdige, orale preparater | |
| AU586410B2 (en) | New cyclic benzenesulfonamides, process for their preparation and their use as active substance of pharmaceutical compositions | |
| WO2003045326A3 (en) | Method for preparing and using polyoxyethylated castor oil in pharmaceutical compositions | |
| IL129616A0 (en) | Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes | |
| CA2294670A1 (en) | Composition suitable as food integrator and for the treatment of intestinal disorders and alterations of the bacterial flora | |
| IE870577L (en) | Topical amide preparation | |
| IL129625A0 (en) | Novel (-)-enantionmers of CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes | |
| DK0751940T3 (da) | Sesquiterpenderivater | |
| NO972605L (no) | Ny fremgangsmåte for fremstilling av ranitidin |